Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes.

PubWeight™: 2.00‹?› | Rank: Top 2%

🔗 View Article (PMID 19487594)

Published in Circulation on June 01, 2009

Authors

John G Webb1, Lukas Altwegg, Robert H Boone, Anson Cheung, Jian Ye, Samuel Lichtenstein, May Lee, Jean Bernard Masson, Christopher Thompson, Robert Moss, Ron Carere, Brad Munt, Fabian Nietlispach, Karin Humphries

Author Affiliations

1: St. Paul's Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada. webb@providencehealth.bc.ca

Articles citing this

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11

One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63

Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol (2010) 1.23

Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol (2011) 1.22

Current management of calcific aortic stenosis. Circ Res (2013) 1.18

Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Imaging (2015) 1.14

The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience. Clin Res Cardiol (2012) 1.09

Potential role of three-dimensional rotational angiography and C-arm CT for valvular repair and implantation. Int J Cardiovasc Imaging (2011) 1.02

Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg (2013) 0.99

Patient-specific modeling of biomechanical interaction in transcatheter aortic valve deployment. J Biomech (2012) 0.92

Towards real-time cardiovascular magnetic resonance-guided transarterial aortic valve implantation: in vitro evaluation and modification of existing devices. J Cardiovasc Magn Reson (2010) 0.92

Silent cerebral infarcts associated with cardiac disease and procedures. Nat Rev Cardiol (2013) 0.89

Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol (2009) 0.89

Functional status and quality of life after transcatheter aortic valve replacement: a systematic review. Ann Intern Med (2014) 0.87

Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis. J Interv Card Electrophysiol (2011) 0.84

A systematic review of transapical aortic valve implantation. Ann Cardiothorac Surg (2012) 0.84

There are two sides to everything: two case reports on sequelae of rescue interventions to treat complications of transcatheter aortic valve implantation of the Medtronic CoreValve prosthesis. Clin Res Cardiol (2010) 0.84

A review of most relevant complications of transcatheter aortic valve implantation. ISRN Cardiol (2013) 0.84

New conduction abnormalities after TAVI--frequency and causes. Nat Rev Cardiol (2012) 0.83

Transapical aortic valve implantation - a rescue procedure for patients with aortic stenosis and "porcelain aorta". Arch Med Sci (2011) 0.82

Patient selection for transcatheter aortic valve implantation: An interventional cardiology perspective. Ann Cardiothorac Surg (2012) 0.82

Aortic stenosis: An update. World J Cardiol (2010) 0.81

Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications. Cardiovasc Diagn Ther (2013) 0.81

Valvular disease: transcatheter aortic valve implantation-time for wider use? Nat Rev Cardiol (2009) 0.80

Transcatheter treatment approaches for aortic valve disease. Int J Cardiovasc Imaging (2011) 0.79

Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis (2011) 0.78

Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial). Am J Cardiol (2014) 0.78

Initial experience of two national centers in transcatheter aortic prosthesis implantation. Arq Bras Cardiol (2014) 0.78

Artificial valves "up to date" in Japan. J Artif Organs (2010) 0.77

Transcatheter resection of the native aortic valve prior to endovalve implantation - A rational approach to reduce TAVI-induced complications. Ann Cardiothorac Surg (2012) 0.77

CT predictors of post-procedural aortic regurgitation in patients referred for transcatheter aortic valve implantation: an analysis of 105 patients. Int J Cardiovasc Imaging (2013) 0.77

Transfemoral aortic valve implantation in severe aortic stenosis patients with prior mitral valve prosthesis. Postepy Kardiol Interwencyjnej (2015) 0.77

Evaluation of calcium loss after transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg (2013) 0.76

[Experience and learning curve with transapical aortic valve implantation]. Herz (2009) 0.76

In-hospital resource utilization in surgical and transcatheter aortic valve replacement. BMC Cardiovasc Disord (2015) 0.75

The next revolution: percutaneous aortic valve replacement. Rambam Maimonides Med J (2010) 0.75

Change in quality of life after transcatheter aortic valve implantation and aortic valve replacement surgery in Australian patients aged ≥ 75 years: the effects of EuroSCORE and patient operability. J Geriatr Cardiol (2015) 0.75

The Odyssey of TAVR from concept to clinical reality. Tex Heart Inst J (2014) 0.75

Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation. Clin J Am Soc Nephrol (2017) 0.75

Evaluation of embolic deflection device using optical particle tracking. Proc SPIE Int Soc Opt Eng (2013) 0.75

Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement. Ann Transl Med (2016) 0.75

Transesophageal echocardiography measurements of aortic annulus diameter using biplane mode in patients undergoing transcatheter aortic valve implantation. Cardiovasc Ultrasound (2013) 0.75

Transcatheter, valve-in-valve transapical aortic and mitral valve implantation, in a high risk patient with aortic and mitral prosthetic valve stenoses. Ann Card Anaesth (2015) 0.75

Transcatheter aortic valve implantation complicated by acute pericardial tamponade. Postepy Kardiol Interwencyjnej (2014) 0.75

Impact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysis. PLoS One (2015) 0.75

Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation. World J Cardiol (2014) 0.75

Femoral artery anatomy-tailored approach in transcatheter aortic valve implantation. Postepy Kardiol Interwencyjnej (2017) 0.75

Management of percutaneous self-expanding bioprosthesis migration. Clin Res Cardiol (2010) 0.75

[Transcatheter aortic valve replacement: when should it be used in aortic stenosis?]. Wien Med Wochenschr (2012) 0.75

Transcatheter tricuspid valve-in-valve replacement: one-year results : Alternative to surgery in high-risk patients. Heart Vessels (2016) 0.75

The development of transcatheter aortic valve replacement (TAVR). Glob Cardiol Sci Pract (2016) 0.75

Articles by these authors

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2008) 21.36

Primer3--new capabilities and interfaces. Nucleic Acids Res (2012) 20.34

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2009) 12.51

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2010) 10.97

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2011) 8.62

Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09

Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation (2006) 3.94

Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest. JAMA (2004) 3.80

Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation (2010) 3.65

Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation (2007) 3.44

The genomics education partnership: successful integration of research into laboratory classes at a diverse group of undergraduate institutions. CBE Life Sci Educ (2010) 3.42

Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation (2006) 2.88

BLAST: a more efficient report with usability improvements. Nucleic Acids Res (2013) 2.77

Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg (2006) 2.61

The potential economic impact of restricted access to angiotensin-receptor blockers. CMAJ (2011) 2.22

Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation (2013) 2.11

Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol (2007) 2.11

Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv (2011) 2.06

Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol (2009) 2.05

Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol (2011) 2.02

Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ (2009) 2.02

Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv (2011) 1.98

Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv (2008) 1.98

Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis (2005) 1.92

Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg (2006) 1.91

Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol (2009) 1.91

Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging (2008) 1.82

Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J (2009) 1.81

The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78

Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock (2013) 1.74

Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.67

Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation (2012) 1.66

Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Clin Respir J (2014) 1.58

Comparison of visual performance after implantation of 3 types of intraocular lenses: accommodative, multifocal, and monofocal. Eur J Ophthalmol (2014) 1.57

Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis. Ann Thorac Surg (2010) 1.57

Class effects of statins in elderly patients with congestive heart failure: a population-based analysis. Am Heart J (2007) 1.53

Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv (2009) 1.53

Treating the right patient at the right time: access to specialist consultation and non-invasive testing. Can J Cardiol (2006) 1.52

Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J (2010) 1.51

Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ (2008) 1.51

Injection drug use and right sided endocarditis. Heart (2003) 1.49

Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc Interv (2012) 1.45

Performance of user independent echocardiographic border detection algorithm: comparison with human observer variability. Int J Cardiovasc Imaging (2005) 1.44

Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv (2010) 1.43

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. CMAJ (2005) 1.43

Comparing invasive and noninvasive management strategies for acute myocardial infarction using administrative databases. Am Heart J (2008) 1.40

A modified protocol for retrograde cerebral perfusion: magnetic resonance spectroscopy in pigs. Eur J Cardiothorac Surg (2012) 1.40

A successful 4S heart transplantation. Can J Cardiol (2011) 1.39

A safe route to work? Accident experience of World Bank Group bike commuters. J Occup Environ Med (2009) 1.39

Left main dissection conservatively managed with optical coherence tomography guidance. Catheter Cardiovasc Interv (2013) 1.38

Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol (2012) 1.38

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer. J Immunol (2012) 1.38

3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol (2012) 1.37

Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv (2011) 1.37

A cell-intrinsic role for Mst1 in regulating thymocyte egress. J Immunol (2009) 1.35

CCORT/CCS quality indicators for acute myocardial infarction care. Can J Cardiol (2003) 1.35

Artificial microRNA-mediated virus resistance in plants. J Virol (2007) 1.28

Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol (2009) 1.25

Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. Opt Lett (2004) 1.23

Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg (2009) 1.22

Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol (2012) 1.22

Technical considerations to avoid pitfalls during transapical aortic valve implantation. J Thorac Cardiovasc Surg (2010) 1.21

Transcatheter closure of paravalvular defects using a purpose-specific occluder. JACC Cardiovasc Interv (2010) 1.20

The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg (2005) 1.20

Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. JACC Cardiovasc Interv (2011) 1.20